Holly Lee

6PUBLICATIONS
31CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2025
Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell-Redirecting Immunotherapies.

Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond

|Jan 09, 2024
BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms.

Holly Lee, Paola Neri, Nizar J Bahlis

|Nov 07, 2023
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma.

Paola Neri, Benjamin G Barwick, David Jung

|Jun 07, 2021
Treatment response measurements and survival outcomes in a cohort of newly diagnosed AL amyloidosis.

Victor H Jimenez-Zepeda, Holly Lee, Sylvia McCulloch

|Nov 16, 2020
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.

Holly Lee, Jason Tay, Peter Duggan

|Feb 22, 2020
Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera.

Holly Lee, Sylvia McCulloch, Etienne Mahe

Pageof 1

Frequent Collaborators

3 joint publications

Paola Neri

3 joint publications

Nizar J Bahlis

2 joint publications

Victor H Jimenez-Zepeda

2 joint publications

Sungwoo Ahn